期刊文献+

子宫平滑肌肉瘤化疗的研究进展 被引量:5

原文传递
导出
摘要 化疗是子宫平滑肌肉瘤辅助治疗的首选。虽然子宫平滑肌肉瘤对化疗并不是很敏感,但是肉瘤具有早期血行转移的临床特点,因此,辅助全身化疗,对于消除子宫平滑肌肉瘤的亚临床转移和盆腔外扩散有重要意义,已成为治疗子宫平滑肌肉瘤必不可少的手段。Wu等研究发现,辅助化疗可提高子宫平滑肌肉瘤患者的生存时间和无复发生存时间。晚期或复发的子宫平滑肌肉瘤患者一般常规采用全身化疗,因单药治疗疗效较差,故主张联合化疗。化疗方案多以蒽环类或异环磷酰胺为主的联合化疗。但是,目前国内、外尚无统一规范的化疗方案。
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2008年第3期233-235,共3页 Chinese Journal of Obstetrics and Gynecology
  • 相关文献

参考文献21

  • 1Wu TI, Chang TC, Hsueh S, et al. Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma. Gynecol Oncol, 2006, 100: 166-172.
  • 2Anderson S, Aghajanian C. Temozolomide in uterine leiomyosarcomas. Gynecol Oncol, 2005, 98:99-103.
  • 3Hensley ML, Maki R, Venkatraman E, et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase Ⅱ trial J Clin Oncol, 2002, 20:2824-2831.
  • 4Omura GA, Blessing JA, Major F, et al. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study. J Clin Oncol, 1985, 3:1240-1245.
  • 5Muss HB, Bundy B, DiSaia PJ, et al. Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide ( a phase Ⅲ trial of the Gynecologic Oncology Group). Cancer, 1985, 55 : 1648-1653.
  • 6Odunsi K, Moneke V, Tammela J, et al. Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up. Int J Gynecol Cancer, 2004, 14:659-664.
  • 7Sutton G, Blessing J, Hanjani P, et al. Phase Ⅱ evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol, 2005, 96:749-752.
  • 8Sutton GP, Blessing JA, Barrett R J, et al. Phase Ⅱ trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study. Am J Obstet Gynecol, 1992, 166:556-559.
  • 9Sutton G, Blessing JA, Malfetano JH. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol, 1996, 62: 226-229.
  • 10Leyvraz S, Zweifel M, Jundt G, et al. Long-term results of a multicenter SAKK trial on high-dose ifosfamide and doxorubicin in advanced or metastatic gynecologic sarcomas. Ann Oncol, 2006, 17:646-651.

同被引文献39

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部